B. Capaldo

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

P. Choyke, M. Merino, S. Harmon, 2020, medRxiv.

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

S. Trostel, K. Kelly, A. Sowalsky, 2022, Discover Oncology.

Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1 b in heart failure

J. Garmey, K. Bilchick, C. McNamara, 2020 .